Herzschrittmachertherapie und Elektrophysiologie最新文献_第3页

[2023 Annual Report of the German Pacemaker and Defibrillator Register-Part 2: Implantable cardioverter defibrillators (ICD)]. [2023年德国心脏起搏器和除颤器登记册年度报告-第2部分：植入式心律转复除颤器（ICD）]。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2026-06-01 Epub Date: 2026-03-09 DOI: 10.1007/s00399-026-01143-8

Heiko Burger, Bernd Nowak, Uwe Wiegand, Carsten Israel, Bernd Lemke, Christof Kolb, Andreas Hain, Andreas Markewitz

引用次数: 0

Neuigkeiten aus der Young EP. 来自Young EP的消息。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2026-06-01 DOI: 10.1007/s00399-026-01151-8

引用次数: 0

[Late complications after atrial fibrillation ablation : Diagnosis and management]. 房颤消融后的晚期并发症：诊断和处理。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2026-06-01 Epub Date: 2026-05-20 DOI: 10.1007/s00399-026-01154-5

Thomas Deneke, Kinan Kneizeh, Andrea Brinker-Paschke, Arno P Bößenecker, Jakub Tomala, Ilkin Maharamli, Thomas Winkler, Matthias Pauschinger, Christopher Kowalewski

{"title":"[Late complications after atrial fibrillation ablation : Diagnosis and management].","authors":"Thomas Deneke, Kinan Kneizeh, Andrea Brinker-Paschke, Arno P Bößenecker, Jakub Tomala, Ilkin Maharamli, Thomas Winkler, Matthias Pauschinger, Christopher Kowalewski","doi":"10.1007/s00399-026-01154-5","DOIUrl":"10.1007/s00399-026-01154-5","url":null,"abstract":"Delayed complications may occur up to weeks after atrial fibrillation (AF) ablation and are usually a consequence of initial injury during ablation and ongoing processes progressing to severe symptomatic but late-onset events. A structured clinical follow-up of patients to appraise for late complications is therefore imperative for all centers performing AF ablations. Late complications should also be reported when testing new ablation technologies. Red flag symptoms like fever, neurological events, and syncope but also delayed onset thoracic pain, dyspnea, exercise intolerance or gastrointestinal symptoms within the first months after AF ablation should trigger standardized diagnostic testing to evaluate for complications like esophageal injury/esophagoatrial fistula, gastroparesis, pulmonary vein stenosis (can become symptomatic even later), diaphragmatic paralysis, or late pericarditis/pericardial effusion. Whereas severe late complications are rare, the remote onset of associated symptoms warrants a high degree of awareness of all medical disciplines involved in the follow-up and also on the patient side to assure appropriate management without further delay. Indicative symptoms, incidences, and standardized management workflows for late complications like esophagoatrial fistula, gastroparesis, pulmonary vein stenosis, phrenic nerve injury/diaphragmatic palsy, and late pericarditis/pericardial effusion are discussed. Different imaging modalities have been used to clarify diagnosis and clinical relevance of these complications. Treatment options may range from wait-and-watch to emergency surgical interventions.","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"139-150"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147976342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Complications in electrophysiology]. [电生理并发症]。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2026-06-01 Epub Date: 2026-05-13 DOI: 10.1007/s00399-026-01156-3

David Duncker, Philipp Sommer

引用次数: 0

[Emergency pharmacotherapy in rhythmology]. [心律失常的紧急药物治疗]。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2026-06-01 Epub Date: 2026-02-28 DOI: 10.1007/s00399-026-01140-x

Boris A Hoffmann

{"title":"[Emergency pharmacotherapy in rhythmology].","authors":"Boris A Hoffmann","doi":"10.1007/s00399-026-01140-x","DOIUrl":"10.1007/s00399-026-01140-x","url":null,"abstract":"Acute cardiac arrhythmias are among the most common and prognostically relevant emergency situations in clinical cardiac electrophysiology. They range from bradycardia and supraventricular tachycardia to atrial fibrillation and atrial flutter to potentially life-threatening ventricular tachyarrhythmias and electrical storm. In these situations, rapid, structured and guideline-based pharmacotherapy is essential to prevent hemodynamic instability and mortality.The selection of appropriate emergency medication depends primarily on the underlying arrhythmia, the hemodynamic situation and individual patient factors such as structural heart disease, heart failure and comorbidities. In addition to classical antiarrhythmic drugs, substances that act on the atrioventricular (AV) node, beta blockers, calcium channel blockers, adenosine, glycosides and catecholamines also play a central role in acute treatment.As no new antiarrhythmic drugs have been approved for clinical practice in the past 15 years, established substances continue to be of particular importance. In addition, antiarrhythmic drugs that are not regularly available in Germany, such as procainamide or mexiletine, are also being discussed, as they may be prognostically relevant, particularly in complex bail-out situations involving ventricular arrhythmias.","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"239-247"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147321983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Position paper of the German Society of Cardiology-quality criteria for performing catheter ablation of atrial fibrillation: executive summary]. [德国心脏病学会立场文件-房颤导管消融的质量标准：执行摘要]。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2026-06-01 Epub Date: 2026-05-19 DOI: 10.1007/s00399-026-01149-2

Daniel Steven, Julian Chun, Isabel Deisenhofer, Thomas Deneke, Maria Papathanasiou, Boris Schmidt, Andreas Rillig, Stephan Willems, Maura M Zylla, Christian Veltmann, Lars Eckardt

{"title":"[Position paper of the German Society of Cardiology-quality criteria for performing catheter ablation of atrial fibrillation: executive summary].","authors":"Daniel Steven, Julian Chun, Isabel Deisenhofer, Thomas Deneke, Maria Papathanasiou, Boris Schmidt, Andreas Rillig, Stephan Willems, Maura M Zylla, Christian Veltmann, Lars Eckardt","doi":"10.1007/s00399-026-01149-2","DOIUrl":"10.1007/s00399-026-01149-2","url":null,"abstract":"The updated German Society of Cardiology (DGK) position paper on catheter ablation of atrial fibrillation (AF) [1] presents the current evidence, techniques, and quality standards, which have evolved significantly since 2017 alongside indications, technology, and the role of ablation in therapy. Pulmonary vein isolation (PVI) remains the cornerstone of AF ablation. In addition to established procedures such as radiofrequency and cryoballoon ablation, pulsed field ablation (PFA) is gaining importance. For persistent AF, clear recommendations beyond PVI are still lacking, despite growing evidence supporting adjunctive ablation strategies. The healthcare landscape shows a marked increase in ablations, with same day discharge procedures recommended only for carefully selected patients. Precise patient selection-including medical history, risk factors, and imaging-is critical for procedural success and safety. The importance of periprocedural management and structured follow-up is emphasized. Complications such as pericardial tamponade, stroke, and phrenic nerve injury require structured protocols and experienced teams. Particularly in patients with heart failure, ablation may offer prognostic benefits. Certification of centers by the DGK supports quality assurance. New developments, such as artificial intelligence (AI)-assisted ablation planning and studies on postablation anticoagulation strategies, are expected to further influence clinical practice.","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"229-238"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13212626/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147977015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Device treatment in adults with congenital heart defects]. 成人先天性心脏缺陷的器械治疗。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2026-06-01 Epub Date: 2026-03-09 DOI: 10.1007/s00399-026-01145-6

Adrian Reinhardt, Götz Buchwalsky, Leon Iden, Victoria Johnson, Andreas Rillig, Arian Sultan, David Duncker, Phillip Attanasio, Philipp Sommer, Till Althoff, Tillmann Dahme, Sascha Rolf, Daniel Steven

引用次数: 0

Value of para-Hisian pacing in patients with accessory pathways in addition to 3D mapping. 旁希氏起搏在辅助通路患者中的应用价值。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2026-06-01 Epub Date: 2026-05-13 DOI: 10.1007/s00399-026-01155-4

Stela Paradzik, Harilaos Bogossian, Fares Ali Mohammed Ai-Raimi, Konstantinos Iliodromitis

引用次数: 0

Mitteilungen aus der Arbeitsgruppe Elektrophysiologie und Rhythmologie (AGEP). 电生理学和节律学工作组（AGEP）。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2026-06-01 DOI: 10.1007/s00399-026-01152-7

引用次数: 0

[The EHRA/HRS/APHRS/LAHRS/AEPC consensus statement on the management of atrial tachycardias : Implications of the SMART-AT 10-point plan for clinical practice and healthcare structures]. [EHRA/HRS/APHRS/LAHRS/AEPC关于房性心动过速管理的共识声明：SMART-AT 10点计划对临床实践和医疗结构的影响]。

Herzschrittmachertherapie und Elektrophysiologie Pub Date : 2026-06-01 Epub Date: 2026-03-26 DOI: 10.1007/s00399-026-01148-3

Ann-Kathrin Kahle, Fares-Alexander Alken, Christoph Stellbrink, Stefan Perings, Lars Eckardt, Nikolaos Dagres, Christian Veltmann, Philipp Sommer, K R Julian Chun, Anja Schade, Shaojie Chen, Christian Perings, Maura M Zylla, Isabel Deisenhofer, Daniel Steven, Thomas Rostock, Stephan Willems, Christian Meyer

{"title":"[The EHRA/HRS/APHRS/LAHRS/AEPC consensus statement on the management of atrial tachycardias : Implications of the SMART-AT 10-point plan for clinical practice and healthcare structures].","authors":"Ann-Kathrin Kahle, Fares-Alexander Alken, Christoph Stellbrink, Stefan Perings, Lars Eckardt, Nikolaos Dagres, Christian Veltmann, Philipp Sommer, K R Julian Chun, Anja Schade, Shaojie Chen, Christian Perings, Maura M Zylla, Isabel Deisenhofer, Daniel Steven, Thomas Rostock, Stephan Willems, Christian Meyer","doi":"10.1007/s00399-026-01148-3","DOIUrl":"10.1007/s00399-026-01148-3","url":null,"abstract":"Atrial tachycardias (AT) represent an increasingly common cause of morbidity and mortality. Driven by substantial advances in mapping and ablation technologies, the mechanistic understanding and therapeutic strategies for AT management have evolved rapidly in recent years, and catheter ablation is now regarded as the most effective strategy for maintaining sinus rhythm. Against this background, the recently published international clinical consensus statement on the management of patients with AT introduces, for the first time, a structured 10-point plan for \"SMART-AT care\" as a framework for the diagnosis and treatment of regular AT. This review highlights key developments and clinical implications, taking into account recent changes within the healthcare system.","PeriodicalId":52403,"journal":{"name":"Herzschrittmachertherapie und Elektrophysiologie","volume":" ","pages":"217-228"},"PeriodicalIF":0.0,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147516673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0